Overview

NOGO for an Overactive Bladder

Status:
Recruiting

Trial end date:
2021-03-01

Target enrollment:

Participant gender:

Summary

This is a double-blind, randomized and placebo-controlled study to evaluate the safety and effectiveness of NoGo, a standardized extract from Angelica archangelica, on overactive bladder

Phase:

Phase 2

Details

Lead Sponsor:

SagaNatura

Collaborator:

Universidad Politecnica de Madrid